Skip to main content
. 2013 Jan-Feb;39(1):76–83. doi: 10.1590/S1806-37132013000100011

Table 2. Comorbidities in the 40 tuberculosis patients treated with fixed-dose combination tablets in the intensive phase of treatment between November of 2010 and October of 2011 in the greater metropolitan area of Goiânia, Brazil.

Comorbidities Patients
n (%)
No comorbidities 26 (65.0)
HIV positivity 2 (5.0)
Diabetes mellitus 5 (12.5)
Cardiovascular disease 2 (5.0)
Pulmonary disease 2 (5.0)
Alcoholism 3 (7.5)